Hospices across the country have seen recent shifts in their clinical and strategic growth leadership teams. Aveanna Healthcare Welcomes New Chief Growth Officer Atlanta-headquartered Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has announced Matt Haglund as its new chief growth officer. Haglund joined the healthcare company in 2021. He most recently led the development of Aveanna’s […]
Atlanta-headquartered Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has seen recent growth across all three of its healthcare segments. The company is narrowing its strategic sights toward hospice and home health. Aveanna offers hospice and home health, private duty and medical solution services across 39 states. The company provides care to medically complex and chronically ill […]
Aveanna Healthcare (Nasdaq: AVAH) is leaning hard into its preferred payer and government affairs strategies to foster growth in its home health and hospice segment and other businesses. The company’s preferred payer strategy is focused largely on Medicare Advantage and Medicaid Managed Care Plans. Aveanna set a goal for eight additional payer agreements in 2026 […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) is committed to expanding its home health and hospice business through acquisitions during 2026 and beyond. The company is currently integrating two non-hospice companies that it acquired last year, First Home Care and Thrive Pediatrics. More deals are likely on the way, according to CEO Jeff Shaner. “We are committed […]
As Aveanna Healthcare Holdings (Nasdaq: AVAH) considers potential acquisitions, hospices are not on the menu due to their high price tags. Hospice multiples skyrocketed during the boom M&A years of 2019 through 2022, reaching as high a 26x, sometimes more. As transactions slowed down between 2023 and 2025, one contributing factor was a disconnect between […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) foresees that home health and hospice will be a growth engine as it moves into the new year. The company expects that its home health and hospice segment will grow organically by 5% to 7% in 2026. This would represent a normalization after a period of double-digit growth for the […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) expects 5% to 7% company-wide growth in the coming year, achieving through a five-pronged strategy. These efforts include strengthening relationships with payers, finding opportunities to reduce costs, modernizing its medical solutions services, optimizing capital structure and cash flow, and increasing engagement among staff and leadership. Aveanna’s preferred-payer and government affairs […]
Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has a strong appetite for acquisitions, but has held off due to high valuations in the hospice space and uncertain home health reimbursement rates. Aveanna provides hospice, home health and private duty care services. The company sees positive growth momentum heading into the final months of 2025, Aveanna CEO […]
Aveanna Healthcare Holdings (Nasdaq: AVAH) is hungry for acquisitions, but hospice transactions are likely not on the menu. Aveanna’s expanding hospice and home health business has largely included a focus on organic growth and tuck-ins across its existing geographic markets. Acquisitions could make up a larger portion of its strategy on the near horizon, according […]
Issues surrounding Medicare fraud are “top of mind” for hospice providers, according to Jim Melancon, senior vice president of government affairs at Aveanna Healthcare Holdings (Nasdaq: AVAH). Reports of hospice fraud have proliferated in recent years, particularly in the four hotbed states of California, Arizona, Nevada and Texas. Fraudulent operators have used a slew of […]
